granisetron and Kahler Disease

granisetron has been researched along with Kahler Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Console, G; Ferreri, A; Gentile, M; Gori, M; Loteta, B; Martino, M; Morabito, A; Moscato, T; Naso, V; Paviglianiti, A; Pitino, AL; Porto, G; Provenzano, PF; Rossi, M; Tripepi, G1
Iida, H; Kojima, Y; Matsumoto, S; Miyazawa, K; Nagai, H; Nakamura, A1
Burhenne, J; Egerer, G; Freiberger, A; Goldschmidt, H; Gronkowski, M; Ho, AD; Hüsing, J; Mikus, G; Neben, K; Pelzl, le H; Schmitt, T; Thalheimer, M1
Belkacémi, Y; Gorin, NC; Laporte, JP; Laugier, A; Ozsahin, M; Pène, F; Rio, B; Sutton, L; Touboul, E1
Araújo Pereira, ME; Carmo, JA; Juncal, C; Lacerda, JF; Lacerda, JM; Lourenço, MF; Martins, C; Rodrigues, A1

Trials

2 trial(s) available for granisetron and Kahler Disease

ArticleYear
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-20, Volume: 32, Issue:30

    Topics: Aprepitant; Dexamethasone; Double-Blind Method; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Morpholines; Multiple Myeloma; Nausea; Prospective Studies; Quality of Life; Transplantation, Autologous; Vomiting

2014
Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
    Transplantation proceedings, 2000, Volume: 32, Issue:8

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Indoles; Leukemia; Male; Multiple Myeloma; Myelodysplastic Syndromes; Nausea; Ondansetron; Transplantation, Autologous; Transplantation, Homologous; Tropisetron; Vomiting

2000

Other Studies

3 other study(ies) available for granisetron and Kahler Disease

ArticleYear
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2020, Volume: 59, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Multiple Myeloma; Nausea; Prospective Studies; Vomiting; Young Adult

2020
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
    Oncology, 2017, Volume: 93, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Aprepitant; Cost-Benefit Analysis; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Vomiting

2017
Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
    International journal of radiation oncology, biology, physics, 1996, Aug-01, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Age Factors; Antiemetics; Body Weight; Bone Marrow Transplantation; Diuresis; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Sex Factors; Whole-Body Irradiation

1996